NFE2L2 and familial pancreatic carcinoma: Furthermore, inhibiting the Nrf2 signalling pathway could reverse the drug resistance and increase the sensitivity of pancreatic cancer cells to chemotherapy (Zhou et al., 2019; Kim et al., 2020).